BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schuetz C, Anazawa T, Cross SE, Labriola L, Meier RPH, Redfield RR 3rd, Scholz H, Stock PG, Zammit NW; IPITA YIC Young Investigator Committee. β Cell Replacement Therapy: The Next 10 Years. Transplantation 2018;102:215-29. [PMID: 28885496 DOI: 10.1097/TP.0000000000001937] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Smink AM, Rodriquez S, Li S, Ceballos B, Corrales N, Alexander M, Koster T, de Haan BJ, Lakey JRT, de Vos P. Successful Islet Transplantation Into a Subcutaneous Polycaprolactone Scaffold in Mice and Pigs. Transplant Direct 2023;9:e1417. [PMID: 36591328 DOI: 10.1097/TXD.0000000000001417] [Reference Citation Analysis]
2 Bolla AM, Montefusco L, Pastore I, Lunati ME, Ben Nasr M, Fiorina P. Benefits and Hurdles of Pancreatic β-Cell Replacement. Stem Cells Transl Med 2022:szac058. [PMID: 36073717 DOI: 10.1093/stcltm/szac058] [Reference Citation Analysis]
3 Anazawa T, Ito T, Hata K, Masui T, Taura K. Cell Transplantation. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases 2022. [DOI: 10.1007/978-981-19-0063-1_70] [Reference Citation Analysis]
4 Takaichi S, Tomimaru Y, Akagi T, Kobayashi S, Fukuda Y, Toya K, Asaoka T, Iwagami Y, Yamada D, Akita H, Noda T, Gotoh K, Doki Y, Akashi M, Eguchi H. Three-dimensional Vascularized β-cell Spheroid Tissue Derived From Human Induced Pluripotent Stem Cells for Subcutaneous Islet Transplantation in a Mouse Model of Type 1 Diabetes. Transplantation 2022;106:48-59. [PMID: 34905762 DOI: 10.1097/TP.0000000000003745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wu S, Wang L, Fang Y, Huang H, You X, Wu J. Advances in Encapsulation and Delivery Strategies for Islet Transplantation. Adv Healthc Mater 2021;10:e2100965. [PMID: 34480420 DOI: 10.1002/adhm.202100965] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
6 Foo JB, Looi QH, Chong PP, Hassan NH, Yeo GEC, Ng CY, Koh B, How CW, Lee SH, Law JX. Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine. Stem Cells Int 2021;2021:2616807. [PMID: 34422061 DOI: 10.1155/2021/2616807] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
7 Pomposelli T, Schuetz C, Wang P, Yamada K. A Strategy to Simultaneously Cure Type 1 Diabetes and Diabetic Nephropathy by Transplant of Composite Islet-Kidney Grafts. Front Endocrinol (Lausanne) 2021;12:632605. [PMID: 34054721 DOI: 10.3389/fendo.2021.632605] [Reference Citation Analysis]
8 Ghila L, Legøy TA, Mathisen AF, Abadpour S, Paulo JA, Scholz H, Ræder H, Chera S. Chronically Elevated Exogenous Glucose Elicits Antipodal Effects on the Proteome Signature of Differentiating Human iPSC-Derived Pancreatic Progenitors. Int J Mol Sci 2021;22:3698. [PMID: 33918250 DOI: 10.3390/ijms22073698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Coe TM, Markmann JF, Rickert CG. Current status of porcine islet xenotransplantation. Curr Opin Organ Transplant 2020;25:449-56. [PMID: 32773503 DOI: 10.1097/MOT.0000000000000794] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
10 Awata T, Kenmochi T, Tomimaru Y, Eguchi H, Ito T, Shimoda M. Pancreas transplantation for type 1 diabetes in Japan: past, present and future prospects. Glob Health Med 2020;2:360-6. [PMID: 33409415 DOI: 10.35772/ghm.2020.01069] [Reference Citation Analysis]
11 Tada S, Anazawa T, Shindo T, Yamane K, Inoguchi K, Fujimoto N, Nagai K, Masui T, Okajima H, Takaori K, Sumi S, Uemoto S. The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation. Transplant Direct 2020;6:e591. [PMID: 32851124 DOI: 10.1097/TXD.0000000000001045] [Reference Citation Analysis]
12 Stephens CH, Morrison RA, McLaughlin M, Orr K, Tersey SA, Scott-Moncrieff JC, Mirmira RG, Considine RV, Voytik-Harbin S. Oligomeric collagen as an encapsulation material for islet/β-cell replacement: effect of islet source, dose, implant site, and administration format. Am J Physiol Endocrinol Metab 2020;319:E388-400. [PMID: 32543944 DOI: 10.1152/ajpendo.00066.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Stratta RJ, Gruessner AC, Gruessner RW. Pancreas transplantation: Current issues, unmet needs, and future perspectives. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas 2020. [DOI: 10.1016/b978-0-12-814833-4.00031-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Korsgren O, Scholz H. Cellular therapies in preclinical and clinical islet transplantation: Mesenchymal stem cells. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas 2020. [DOI: 10.1016/b978-0-12-814833-4.00064-2] [Reference Citation Analysis]
15 Espona-Noguera A, Ciriza J, Cañibano-Hernández A, Orive G, Hernández RMM, Saenz Del Burgo L, Pedraz JL. Review of Advanced Hydrogel-Based Cell Encapsulation Systems for Insulin Delivery in Type 1 Diabetes Mellitus. Pharmaceutics 2019;11:E597. [PMID: 31726670 DOI: 10.3390/pharmaceutics11110597] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
16 Zammit NW, Walters SN, Seeberger KL, O'Connell PJ, Korbutt GS, Grey ST. A20 as an immune tolerance factor can determine islet transplant outcomes. JCI Insight 2019;4:131028. [PMID: 31581152 DOI: 10.1172/jci.insight.131028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
17 Zammit NW, Walters SN, Seeberger KL, Korbutt GS, Grey ST. A20 is an immune tolerance factor that can determine islet transplant outcomes.. [DOI: 10.1101/770834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Takahashi H, Sakata N, Yoshimatsu G, Hasegawa S, Kodama S. Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus. J Clin Med 2019;8:E249. [PMID: 30781427 DOI: 10.3390/jcm8020249] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
19 Hu C, Jia W. Therapeutic medications against diabetes: What we have and what we expect. Adv Drug Deliv Rev 2019;139:3-15. [PMID: 30529309 DOI: 10.1016/j.addr.2018.11.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
20 Navarro-Tableros V, Gomez Y, Brizzi MF, Camussi G. Generation of Human Stem Cell-Derived Pancreatic Organoids (POs) for Regenerative Medicine. Adv Exp Med Biol 2020;1212:179-220. [PMID: 31025308 DOI: 10.1007/5584_2019_340] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
21 Anazawa T, Okajima H, Masui T, Uemoto S. Current state and future evolution of pancreatic islet transplantation. Ann Gastroenterol Surg 2019;3:34-42. [PMID: 30697608 DOI: 10.1002/ags3.12214] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
22 Tang SC, Jessup CF, Campbell-Thompson M. The Role of Accessory Cells in Islet Homeostasis. Curr Diab Rep 2018;18:117. [PMID: 30267158 DOI: 10.1007/s11892-018-1096-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
23 Kemter E, Denner J, Wolf E. Will Genetic Engineering Carry Xenotransplantation of Pig Islets to the Clinic? Curr Diab Rep 2018;18:103. [PMID: 30229378 DOI: 10.1007/s11892-018-1074-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]